NCT06341998 2025-09-19
SCRRYST
Shandong First Medical University
Phase 2/3 Completed
Clinical Trials
10 trialsNCT04082364 2025-06-08
MAHOGANY
MacroGenics
Phase 2/3 Completed
NCT05865548 2024-08-13
Addition of Aspirin to Standard of Care in Oral Cancer
Banaras Hindu University
Phase 2/3 Completed
NCT00837265 2024-04-03
NEUGR-002
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2/3 Completed
NCT05809336 2023-04-12
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors
Beijing Friendship Hospital
Phase 2/3 Completed
NCT03410693 2022-09-28
FORT-1
Bayer
Phase 2/3 Completed
NCT01829178 2015-05-13
Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma
Tehran University of Medical Sciences
Phase 2/3 Completed
NCT00785421 2015-01-08
PROSPECT
CONKO-Studiengruppe
Phase 2/3 Completed
NCT00243685 2012-01-26
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis
Pierian Biosciences
Phase 2/3 Completed
NCT01015261 2010-11-22
Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients
Tehran University of Medical Sciences
Phase 2/3 Completed